Posaconazole Clinical Trials
5 recruitingDrug
Phase 24Phase 12Not Applicable1
Showing 1–5 of 5 trials
Recruiting
Phase 1Phase 2
Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
Acute Lymphoblastic LeukaemiaAcute Myeloid Leukaemia
AstraZeneca84 enrolled29 locationsNCT07155226
Recruiting
Phase 1Phase 2
A Study of BGB-11417 in Participants With Myeloid Malignancies
Acute Myeloid LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasm
BeiGene260 enrolled46 locationsNCT04771130
Recruiting
Phase 2
Posaconazole Plus PD-1 Inhibitors and Chemotherapy vs PD-1 Inhibitors and Chemotherapy in Neoadjuvant Therapy for Triple Negative Breast Cancer
Breast Cancer
Shandong Cancer Hospital and Institute72 enrolled1 locationNCT06802757
Recruiting
Phase 2
Study of Posaconazole Prophylaxis in Patients Receiving Hematopoietic Stem Cell Allograft (Allo-HSC) at High Risk of Invasive Fungal Infection (IFI)
Hematologic Malignancy
Nantes University Hospital30 enrolled1 locationNCT06541067
Recruiting
Not Applicable
PTX3-targeted Antifungal Prophylaxis
Acute Myeloid LeukemiaGenetic PredispositionCandidiasis+2 more
Bochud Pierre-Yves410 enrolled9 locationsNCT03828773